U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07038746) titled 'Phase 1b Inhaled Epinephrine Study on Systemic Allergic Reactions During Allergy Testing Immunotherapy or Oral Challenge' on June 18.
Brief Summary: The goal of this exploratory study is to evaluate the effects of inhaled epinephrine in subjects, who may not be eligible for the GHL-101 trial, and who are experiencing systemic allergic reaction (SAR) that occur following allergy testing, subcutaneous immunotherapy (SCIT), oral challenges (with food and/or drug) or oral immunotherapy (OIT).
Study Start Date: June, 2025
Study Type: INTERVENTIONAL
Condition:
Hypersensitivity
Anaphylaxis
Intervention:
DRUG: Inhaled Epinephrine
0.1...